Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

US Patent 7906530 · Granted Mar 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds active towards nuclear receptors2025
KRas inhibitors2025
Compounds active towards nuclear receptors2023
Mutant IDH1 inhibitors2020
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic an2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic an2017
Pyrrolotriazinone derivatives as PI3K inhibitors2016
Pyrrolotriazinone derivatives as inhibitors P13K2016
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2016
Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitor2015
4,8-diphenyl-polyazanaphthalene derivatives2012
2-phenylpyran-4-one derivatives as selective COX-2 inhibitors2009